Literature DB >> 10668210

Current understanding of macrophage type 1 cytokine responses during intracellular infections.

Z Xing1.   

Abstract

Macrophages are important effector cells in cell-mediated immunity against intracellular infection. Among cytokines that macrophages are able to release are IL-12 and TNF alpha. IL-12 is a critical linker between the innate and adaptive cell-mediated immunity, capable of Th1 differentiation and IFN gamma release by T and NK cells. IFN gamma is critically required for the activation of macrophage bactericidal activities. Recently emerging evidence suggests that macrophages are able to release not only IL-12 and TNF alpha but also IFN gamma. However, the mechanisms that control the release of each of these type 1 cytokines in macrophages appear different. While macrophages release TNF alpha in an indiscriminate and IL-12-independent way, the release of IL-12, particularly bioactive IL-12 p70, and IFN gamma is under tight control. We are just beginning to understand what controls the release of IL-12 p70, a question of fundamental importance to understanding the mechanisms underlying the initiation of cell-mediated immunity. Our recent findings have shed more insights into the regulatory mechanisms of macrophage IFN gamma responses. It has become evident that IL-12 is required not only for Th1 differentiation but also for IFN gamma responses by both T cells and macrophages during intracellular infection. In this overview, we have discussed about the current understanding of the regulation of macrophage type 1 cytokine responses during intracellular infection, based upon the recent findings from us and others.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10668210     DOI: 10.14670/HH-15.199

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  6 in total

1.  Increased CTLA-4+ T cells may contribute to impaired T helper type 1 immune responses in patients with chronic obstructive pulmonary disease.

Authors:  Dino B A Tan; Teck-Hui Teo; Abdul M Setiawan; Nathanael E Ong; Maja Zimmermann; Patricia Price; Lea-Ann S Kirkham; Yuben P Moodley
Journal:  Immunology       Date:  2017-03-20       Impact factor: 7.397

2.  Persisting Rickettsia typhi Causes Fatal Central Nervous System Inflammation.

Authors:  Anke Osterloh; Stefanie Papp; Kristin Moderzynski; Svenja Kuehl; Ulricke Richardt; Bernhard Fleischer
Journal:  Infect Immun       Date:  2016-04-22       Impact factor: 3.441

3.  Comparison of serum and cell-specific cytokines in humans.

Authors:  J Jason; L K Archibald; O C Nwanyanwu; M G Byrd; P N Kazembe; H Dobbie; W R Jarvis
Journal:  Clin Diagn Lab Immunol       Date:  2001-11

4.  CD1d activation and blockade: a new antitumor strategy.

Authors:  Michele W L Teng; Simon Yue; Janelle Sharkey; Mark A Exley; Mark J Smyth
Journal:  J Immunol       Date:  2009-03-15       Impact factor: 5.422

5.  Immunomodulatory role of Ocimum gratissimum and ascorbic acid against nicotine-induced murine peritoneal macrophages in vitro.

Authors:  Santanu Kar Mahapatra; Subhankari Prasad Chakraborty; Somenath Roy
Journal:  Oxid Med Cell Longev       Date:  2011-12-18       Impact factor: 6.543

6.  Liver Necrosis and Lethal Systemic Inflammation in a Murine Model of Rickettsia typhi Infection: Role of Neutrophils, Macrophages and NK Cells.

Authors:  Stefanie Papp; Kristin Moderzynski; Jessica Rauch; Liza Heine; Svenja Kuehl; Ulricke Richardt; Heidelinde Mueller; Bernhard Fleischer; Anke Osterloh
Journal:  PLoS Negl Trop Dis       Date:  2016-08-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.